Novavax Inc (NVAX)
8.05
-0.01
(-0.12%)
USD |
NASDAQ |
Nov 21, 16:00
7.95
-0.10
(-1.24%)
After-Hours: 18:17
Novavax Profit Margin (Quarterly): -143.5% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -143.5% |
| June 30, 2024 | 39.08% |
| March 31, 2024 | -157.2% |
| December 31, 2023 | -70.40% |
| September 30, 2023 | -592.7% |
| June 30, 2023 | 13.67% |
| March 31, 2023 | |
| December 31, 2022 | -63.32% |
| September 30, 2022 | -26.84% |
| June 30, 2022 | -274.6% |
| March 31, 2022 | 33.64% |
| December 31, 2021 | |
| September 30, 2021 | -180.3% |
| June 30, 2021 | -118.2% |
| March 31, 2021 | -49.80% |
| December 31, 2020 | |
| September 30, 2020 | -125.7% |
| June 30, 2020 | -49.30% |
| March 31, 2020 | -765.9% |
| December 31, 2019 | -361.0% |
| September 30, 2019 | -719.7% |
| June 30, 2019 | -1.18K% |
| March 31, 2019 | -1.09K% |
| December 31, 2018 | -805.2% |
| September 30, 2018 | -576.2% |
| Date | Value |
|---|---|
| June 30, 2018 | -413.0% |
| March 31, 2018 | -480.2% |
| December 31, 2017 | -488.3% |
| September 30, 2017 | -534.1% |
| June 30, 2017 | -660.5% |
| March 31, 2017 | -772.1% |
| December 31, 2016 | -1.06K% |
| September 30, 2016 | -2.05K% |
| June 30, 2016 | -3.17K% |
| March 31, 2016 | -1.83K% |
| December 31, 2015 | -1.35K% |
| September 30, 2015 | -507.6% |
| June 30, 2015 | -147.5% |
| March 31, 2015 | -246.7% |
| December 31, 2014 | -469.2% |
| September 30, 2014 | -240.2% |
| June 30, 2014 | -216.3% |
| March 31, 2014 | -185.1% |
| December 31, 2013 | -160.7% |
| September 30, 2013 | -318.6% |
| June 30, 2013 | -357.8% |
| March 31, 2013 | -260.8% |
| December 31, 2012 | -176.0% |
| September 30, 2012 | -125.2% |
| June 30, 2012 | -83.35% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-765.9%
Minimum
Mar 2020
39.08%
Maximum
Jun 2024
-170.1%
Average
-118.2%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Moderna Inc | 0.70% |
| Inovio Pharmaceuticals Inc | -- |
| Baxter International Inc | 5.19% |
| Halozyme Therapeutics Inc | 47.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -17.08% |
| Gross Profit Margin (Quarterly) | 28.27% |
| Operating Margin (Quarterly) | -158.6% |
| Return on Net Operating Assets | -37.74% |